0001656472-22-000124.txt : 20220818 0001656472-22-000124.hdr.sgml : 20220818 20220818170005 ACCESSION NUMBER: 0001656472-22-000124 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220809 FILED AS OF DATE: 20220818 DATE AS OF CHANGE: 20220818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weigensberg Arye CENTRAL INDEX KEY: 0001937121 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 221178038 MAIL ADDRESS: STREET 1: 111 PETER STREET, SUITE 300 CITY: TORONTO STATE: A6 ZIP: MV5 2H1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 3 1 wf-form3_166085638558537.xml FORM 3 X0206 3 2022-08-09 0 0001656472 Cronos Group Inc. CRON 0001937121 Weigensberg Arye 111 PETER STREET, SUITE 300 TORONTO A6 M5V 2H1 ONTARIO, CANADA 0 1 0 0 See Remarks COMMON SHARES 5505 D RESTRICTED STOCK UNITS COMMON SHARES 38048.0 D COMMON SHARE OPTION (right to buy) 17.68 2024-08-12 COMMON SHARES 2031.0 D The restricted share units ("RSUs") consist of the following: (1) 3,064 unvested RSUs vesting in substantially equal annual installments, with the second of three scheduled vesting dates to occur on December 17, 2022, (2) 7,944 unvested RSUs vesting in substantially equal annual installments with the second of three scheduled vesting dates to occur on May 25, 2022, and (3) 27,040 unvested RSUs vesting in three substantially equal annual installments beginning on May 12, 2023, in each case, subject to continued employment through each applicable date. Each RSU represents a contingent right to receive one common share of the Company. The options were granted August 12, 2019 and vest in quarterly installments over a four-year period. The exercise price is expressed in Canadian dollars. Senior Vice President, Head of Research and Development. Exhibit List: Exhibit 24 - Power of Attorney. Aaron B. Werner, as attorney-in-fact for Arye Weigensberg 2022-08-18 EX-24 2 weigensberg-cronossectio.htm EXHIBIT LIST: EXHIBIT 24 - POWER OF ATTORNEY (WEIGENSBERG)

Exhibit 24

Authorization and Designation to Sign and File  Section 16 Reporting Forms

The undersigned, an executive officer of Cronos Group Inc., a corporation  incorporated under the Business Corporations Act (British Columbia) (the "Company"),  does hereby authorize and designate Robert Madore, Terry Doucet or Aaron Werner,  each with right to substitute and resubstitute, but for only so long as each of them is an  employee of the Company, to sign and file on his behalf the application for the required  Securities and Exchange Commission ("SEC”") electronic CIK/CCC codes and any and  all Forms 3, 4 and 5 and Forms 144 relating to equity securities of the Company with the  SEC pursuant to the requirements of Section 16 of the Securities Exchange Act of 1934  ("Section 16") and Rule 144 under the Securities Act of 1933, as amended.  This  authorization, unless earlier revoked in writing, shall be valid until the undersigned's  reporting obligations under Section 16 and Rule 144 with respect to equity securities of  the Company shall cease.  All prior such authorizations are hereby revoked.

IN WITNESS WHEREOF, the undersigned has executed this Authorization and  Designation this __July ___ day of ________21________, 2022.

/s/Arye Weigensberg
Arye Weigensberg